Moscow State University develops new thyroid gland cancer drug

Moscow State University develops new thyroid gland cancer drugA research team at Lomonosov Moscow State University is developing an innovation y-tracer called ?Astat-211? to fight thyroid gland cancer

A research team at Lomonosov Moscow State University (MSU) is developing an innovation y-tracer called ?Astat-211? to fight thyroid gland cancer, announced MSU?s Skobeltsyn Institute of Nuclear Physics, the prime driver of the new project. The research effort is being pushed by a scientific team led by Prof. O. A. Yuminov. The new y-tracer is based on the 211-At radioactive nuclide, believed to be a powerful anti-tumor weapon, and is expected to be more efficient in cancer therapies while substantially decreasing radiation doses for patients and medical staff, compared to the conventional y-tracers currently using the 131-I nuclide. Unlike the future y-tracer, the 131-I is a source of ?- and ?-rays that possess a considerable penetrating power?up to a few centimeters in biological tissues. This results in exposing patients to a relatively large dose of healthy organ irradiation, while the destruction of cancerous cells is far from efficient...